Biotech Stocks Newsletter – March 16, 2018

0
549

A Shift Is Happening!

The top talent that helped build some of the most successful biotech organizations in the industry, quickly taking therapies to market, and who had a hand in major acquisitions are now part of the leadership team with roles like Chief Executive Officer and Chief Medical Officer at a company that already has a pipeline of novel drug therapies.

SEE MORE DETAILS HERE!


AbbVie Inc (NYSE:ABBV) And Biogen Inc (NASDAQ:BIIB) Working On Withdrawing Marketing Authorizations For ZINBRYTA®

It was today that AbbVie Inc (NYSE:ABBV) and Biogen Inc (NASDAQ:BIIB) made a joint statement regarding the voluntary worldwide withdrawal of ZINBRYTA which is basically about the relapsing multiple sclerosis.

SEE FOR YOURSELF CLICK HERE!


LEAVE A REPLY

Please enter your name here
Please enter your comment!